Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.
Mandate

Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.

February 11, 2019 M&A

Founded in Stockholm in 2012, Tink AB is a cloud-based platform that provides the infrastructure and value-adding data products that are enabling the future of financial services.

Tink’s products can be used to develop standalone services or be integrated into existing banking applications. 

Insight Venture Partners is a leading global venture capital and private equity firm investing in high-growth technology and software companies that are driving transformative change in their industries.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Michaela Cronemyr, Isabelle Jengsell (M&A), Malin Haag, Stina Bengtsson (Financial Services), Sara Strandberg (Employment), Nicklas Thorgerzon (IT/GDPR), Arvid Axelryd (Commercial Agreements), Lisa Hörnqvist (IP) and Frida Ställborn (Real Property).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026